Petco collaborates with Snoop Dogg in new pet-care campaign

Petco collaborates with Snoop Dogg in new pet-care campaign


Petco teams up with hip-hop icon Snoop Dogg for an innovative pet-care campaign.

Courtesy: Petco

Petco has partnered with hip-hop icon Snoop Dogg for a new pet-care campaign, the company said Wednesday.

The collaboration features Petco Picks by Snoop, which include toys, treats and grooming supplies, and offers social content showcasing behind-the-scenes footage of Snoop Dogg with pets, including his reflections on being a devoted dog owner, Petco said in a press release. 

“My pets gotta look good, feel good, smell good,” Snoop Dogg said.

The campaign’s first ad showcases Snoop Dogg as the human form of a Doberman Pinscher, a nod to the rapper’s 1993 hit “Who Am I? (What’s My Name)?” from his debut album “Doggystyle.”

In 2022, American pet owners spent about $136.8 billion on their furry friends, a 13.2% increase from the previous year, according to an American Pet Products Association survey.

“We recognize that pet parents want to get the most for their dollars and are seeking compelling deals for high-quality products wherever they can,” said Katie Nauman, Petco’s chief marketing officer, in a news release.

Americans continue to spend money on pets, even during periods of financial constraint, Petco CEO Ron Coughlin said last year.

The cost for pet services, including veterinary care, was up 10.6% year over year in May, according to the U.S. Department of Labor. Pet food costs were up 13.8% during the same period, the department said.

Shares of Petco are down about 9% year to date, lagging competitor Chewy, whose shares are up about 6% so far this year.

Petco relaunched its Vital Care membership program in March 2022 as part of a push to be more competitive in the pet-care market. The company said in an email that the program provides savings and additional benefits for consumers.



Source

JPMorgan’s top biotech and pharma picks for the second half
Health

JPMorgan’s top biotech and pharma picks for the second half

Biopharmaceutical stocks’ underperformance versus the broader market for a third-straight year is an opportunity for investors, according to JPMorgan. Analyst Chris Schott said in the firm’s June outlook for biopharma that the sector’s poor performance can be traced back to concerns over President Donald Trump’s tariffs and his ” most favored nation ” executive order. […]

Read More
How twin sister triathletes doubled down on sports success to raise health-startup millions from investors
Health

How twin sister triathletes doubled down on sports success to raise health-startup millions from investors

During their last year of completing work for doctoral degrees in physiology, twin sisters Michal Mor and Merav Mor started to compete in Ironman triathlon races. The demand for peak fitness led them to the realize the importance of understanding personal metabolism, and the lack of data being collected on it through devices accessible to […]

Read More
It’s not just AI — China’s quickly gaining an edge over the U.S. in biotech
Health

It’s not just AI — China’s quickly gaining an edge over the U.S. in biotech

Two graduate students research chemical products in a laboratory in Xiwangzhuang Town, Zaozhuang City, Shandong province of China, on Dec. 26, 2023. Nurphoto | Nurphoto | Getty Images BEIJING — For all the attention on U.S.-China competition in artificial intelligence, new studies point to China’s rapid rise in biotechnology, especially for drug and agricultural development. […]

Read More